Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Exp Gerontol
    August 2021
  1. LI P, Wu Q, Li X, Hu B, et al
    Shenqi Yizhi Granule attenuates Abeta1-42 induced cognitive dysfunction via inhibiting JAK2/STAT3 activated astrocyte reactivity.
    Exp Gerontol. 2021;151:111400.
    >> Share

    July 2021
  2. VASCONCELOS-FILHO FSL, da Rocha Oliveira LC, de Freitas TBC, de Pontes PADS, et al
    Effect of involuntary chronic physical exercise on beta-amyloid protein in experimental models of Alzheimer's disease: Systematic review and meta-analysis.
    Exp Gerontol. 2021 Jul 30:111502. doi: 10.1016/j.exger.2021.111502.
    >> Share

  3. VATANABE IP, Pedroso RV, Manzine PR, Chagas MHN, et al
    ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty.
    Exp Gerontol. 2021;149:111303.
    >> Share

    June 2021
  4. GALLO A, Pillet LE, Verpillot R
    New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids.
    Exp Gerontol. 2021;152:111452.
    >> Share

    May 2021
  5. CEZAR NOC, Aprahamian I, Ansai JH, de Oliveira MPB, et al
    Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX).
    Exp Gerontol. 2021;150:111390.
    >> Share

  6. LIU L, Cao J, Huang C, Yuan E, et al
    Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse.
    Exp Gerontol. 2021;147:111274.
    >> Share

  7. YANG I, Arthur RA, Zhao L, Clark J, et al
    The oral microbiome and inflammation in mild cognitive impairment.
    Exp Gerontol. 2021;147:111273.
    >> Share

    April 2021
  8. TZEKAKI EE, Tsolaki M, Pantazaki AlphaA, Geromichalos G, et al
    The pleiotropic beneficial intervention of olive oil intake on the Alzheimer's disease onset via fibrinolytic system.
    Exp Gerontol. 2021 Apr 6:111344. doi: 10.1016/j.exger.2021.111344.
    >> Share

    March 2021
  9. XIAO QY, Ye TY, Wang XL, Han L, et al
    A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease.
    Exp Gerontol. 2021 Mar 27:111336. doi: 10.1016/j.exger.2021.111336.
    >> Share

  10. PINI L, Wennberg AM
    Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.
    Exp Gerontol. 2021;145:111216.
    >> Share

    February 2021
  11. EGASHIRA R, Umezaki Y, Mizutani S, Obata T, et al
    Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
    Exp Gerontol. 2021;144:111189.
    >> Share

    January 2021
  12. FERNANDEZ FX, Kaladchibachi S, Negelspach DC
    Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease.
    Exp Gerontol. 2021;147:111258.
    >> Share

  13. BLASKO I, Defrancesco M, Oberacher H, Loacker L, et al
    Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease.
    Exp Gerontol. 2021 Jan 28:111264. doi: 10.1016/j.exger.2021.111264.
    >> Share

  14. YAN T, Liu B, Wang N, Liao Z, et al
    The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in Abeta1-42 induced mouse model of Alzheimer's disease.
    Exp Gerontol. 2021;147:111263.
    >> Share

  15. SOYSAL P, Tan SG, Smith L
    A comparison of the prevalence of Fear of Falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia.
    Exp Gerontol. 2021;146:111248.
    >> Share

  16. AL-HARRASI AM, Iqbal E, Tsamakis K, Lasek J, et al
    Motor signs in Alzheimer's disease and vascular dementia: Detection through natural language processing, co-morbid features and relationship to adverse outcomes.
    Exp Gerontol. 2021 Jan 12:111223. doi: 10.1016/j.exger.2020.111223.
    >> Share

    December 2020
  17. TZEKAKI EE, Papaspyropoulos A, Tsolaki M, Lazarou E, et al
    Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.
    Exp Gerontol. 2020 Dec 5:111178. doi: 10.1016/j.exger.2020.111178.
    >> Share

  18. LIU Q, Lei C
    Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Exp Gerontol. 2020;144:111187.
    >> Share

  19. ZHANG J, Wang R
    Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-beta induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Exp Gerontol. 2020;144:111180.
    >> Share

  20. SCHIMIDT HL, Carrazoni GS, Garcia A, Izquierdo I, et al
    Strength training or green tea prevent memory deficits in a beta-amyloid peptide-mediated Alzheimer's disease model.
    Exp Gerontol. 2020;143:111186.
    >> Share

    September 2020
  21. YADAV J, Verma AK, Garg RK, Ahmad K, et al
    Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer's disease.
    Exp Gerontol. 2020 Sep 26:111092. doi: 10.1016/j.exger.2020.111092.
    >> Share

    August 2020
  22. WANG R, Zhang J
    Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Abeta-induced neurotoxicity by regulating JAK2.
    Exp Gerontol. 2020 Aug 29:111080. doi: 10.1016/j.exger.2020.111080.
    >> Share

    June 2020
  23. FERNANDES A, Tabuas-Pereira M, Duro D, Lima M, et al
    C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia.
    Exp Gerontol. 2020 Jun 16:111004. doi: 10.1016/j.exger.2020.111004.
    >> Share

    April 2020
  24. KIM YJ, Kim SH, Park Y, Park J, et al
    miR-16-5p is upregulated by amyloid beta deposition in Alzheimer's disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2.
    Exp Gerontol. 2020 Apr 19:110954. doi: 10.1016/j.exger.2020.110954.
    >> Share

  25. MUNDO IG, Vielma NMP, Lopez MG, Fleury A, et al
    DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease.
    Exp Gerontol. 2020 Apr 16:110951. doi: 10.1016/j.exger.2020.110951.
    >> Share

  26. SCARABINO D, Peconi M, Broggio E, Gambina G, et al
    Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease.
    Exp Gerontol. 2020;136:110945.
    >> Share

  27. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Corrigendum to "Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study" [Exp. Gerontol. 131 (2020) 110816].
    Exp Gerontol. 2020 Apr 8:110943. doi: 10.1016/j.exger.2020.110943.
    >> Share

  28. ELSWORTHY RJ, Aldred S
    The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation.
    Exp Gerontol. 2020;132:110838.
    >> Share

    March 2020
  29. MOREL E, Armand S, Assal F, Allali G, et al
    Parkinsonian gait in aging: A feature of Alzheimer's pathology?
    Exp Gerontol. 2020 Mar 2:110905. doi: 10.1016/j.exger.2020.110905.
    >> Share

    February 2020
  30. SINGULANI MP, Pereira CPM, Ferreira AFF, Garcia PC, et al
    Impairment of PGC-1alpha-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease.
    Exp Gerontol. 2020 Feb 18:110882. doi: 10.1016/j.exger.2020.110882.
    >> Share

  31. YAN T, Nian T, Wu B, Xiao F, et al
    Okra polysaccharides can reverse the metabolic disorder induced by high-fat diet and cognitive function injury in Abeta1-42 mice.
    Exp Gerontol. 2020;130:110802.
    >> Share

  32. LIN X, Chen Y, Zhang P, Chen G, et al
    The potential mechanism of postoperative cognitive dysfunction in older people.
    Exp Gerontol. 2020;130:110791.
    >> Share

    December 2019
  33. ZHAO J, Liu P, Hua L, Yang X, et al
    Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population.
    Exp Gerontol. 2019 Dec 21:110813. doi: 10.1016/j.exger.2019.110813.
    >> Share

  34. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study.
    Exp Gerontol. 2019 Dec 17:110816. doi: 10.1016/j.exger.2019.110816.
    >> Share

  35. CAO F, Liu Z, Sun G
    Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-beta induced neurotoxicity by targeting PTEN.
    Exp Gerontol. 2019;130:110814.
    >> Share

    October 2019
  36. ARIANNA V, Sonila A, Sofia P, Alessia G, et al
    Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2019 Oct 21:110754. doi: 10.1016/j.exger.2019.110754.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016